Stephen Mandel - Lone Pine Capital
Holding/activity history for  Blueprint Medicines Corp. (BPMC)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2021   Q2 | 0 | 0 | Sell 100.00% | 0.96 | |
2021   Q1 | 2,709,138 | 0.96 | $97.23 | ||
2020   Q4 | 2,709,138 | 1.10 | Buy | 1.10 | $112.15 |